MDWD

MEDIWOUND LTD

MDWD·M68830112·US·Common Stock·Healthcare - Biotechnology-Activist

MDWD (MEDIWOUND LTD) is held by 44 institutional investors as of Q1 2026. Largest holders: PRICE T ROWE ASSOCIATES INC /MD/ ($11.4M), BlackRock, Inc. ($7.2M), Point72 Asset Management, L.P. ($2.8M). Net institutional sentiment: Mixed.

44
Holders
Avg rating(14 Elite)
$39.6M
Total Value
56% (54)
Fund Consensus
27 buying - 21 selling
MDWDSmart Money Verdict
View all
Held by 44 funds
14 elite
Who's Trading
InsiderFMFox David MortonBuy $25KJun 1, 2026
InsiderFMFox David MortonBuy $142.3Jun 1, 2026
InsiderFMFox David MortonBuy $25KJun 1, 2026
InsiderRSRubinstein SamuelBuy $2KMay 29, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.5.5%May 15, 2026
ActivistHAHOLD Alapkezelo Zrt.8.1%Feb 13, 2026
ActivistRARosalind Advisors, Inc.7.0%Feb 11, 2026
ActivistYLYelin Lapidot Holdings Management Ltd.6.0%Feb 5, 2026
ActivistAIAccess Industries Holdings LLC11.6%Oct 3, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
709,847(+28.0%)$11.4M0.0%-19.47%
35
Decreased
445,834(-2.2%)$7.2M0.0%-19.77%
0
New
175,479$2.8M0.0%-16.92%
36
Increased
159,791(+10.2%)$2.6M0.0%-20.21%
29
Increased
143,770(+15.5%)$2.3M0.0%-19.25%
30
Increased
129,961(+22.1%)$2.1M0.0%-18.28%
31
Increased
121,958(+1.6%)$2M0.0%-11.54%
26
Increased
121,776(+1.7%)$2M0.0%-19.35%
26
Increased
88,473(+19.6%)$1.4M0.0%-18.16%
30
Decreased
59,240(-33.9%)$954,3560.0%-21.74%
0
New
57,547$927,0820.0%-16.92%
38
Increased
44,300(+273.3%)$713,6730.0%-18.15%
40
Increased
24,597(+12.4%)$396,2580.0%-23.15%
27
Decreased
21,407(-11.8%)$344,8670.0%-11.38%
0
New
19,741$318,0280.0%-16.92%
36
Decreased
17,151(-5.2%)$276,3020.0%-9.55%
0
Increased
16,539(+9.5%)$266,4430.0%-20.31%
25
Decreased
13,572(-30.5%)$218,6450.0%-19.20%
0
Decreased
11,787(-41.6%)$189,8850.0%+10.42%
0
Increased
11,321(+4.2%)$182,3720.0%-12.36%
24

Showing 1-20 of 54

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used